Plasmapheresis Controller Feedback for Precise Replacement Fluid Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing therapeutic plasma exchange systems face challenges in efficiently and safely removing plasma from patients and administering a precise amount of replacement fluids or therapeutic agents, particularly in automated procedures.

Innovation Solution

A plasmapheresis system comprising a reusable hardware component and a disposable fluid circuit, equipped with a programmable controller, pumps, and sensors, which monitors plasma collection and initiates delivery of replacement fluids or therapeutic agents, ensuring precise administration based on predetermined volumes or percentages.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If automated plasmapheresis is used to remove plasma and administer replacement fluids, then treatment efficiency is improved, but precise control of replacement fluid administration becomes more difficult

Engineering Contradiction:
Improvetreatment efficiencyVSAvoidreplacement fluid administration precision
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The system incorporates a programmable controller that continuously monitors the volume of plasma removed and automatically adjusts the replacement fluid administration accordingly. The controller receives feedback from sensors measuring plasma volume and uses this information to precisely control the infusion pump that delivers replacement fluids, ensuring accurate replacement based on actual plasma removal.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces manual mechanical control of fluid administration with an automated electronic control system. The programmable controller uses electronic sensors and computerized algorithms to monitor plasma removal and automatically regulate replacement fluid delivery, substituting the need for manual measurement and administration with precision electronic control.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If a disposable fluid circuit is used for plasmapheresis, then safety and ease of sterilization are improved, but device complexity increases

Engineering Contradiction:
ImprovesafetyVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system is divided into two distinct segments: a reusable hardware component containing the pumps and controller, and a disposable fluid circuit that includes all tubing, filters, and connection elements that contact blood. This segmentation allows the disposable portion to be discarded after single use, eliminating sterilization requirements and reducing infection risk, while the reusable portion can be maintained and sterilized according to standard protocols.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs a disposable fluid circuit designed for single-use only. This disposable component includes all elements that come into contact with the patient's blood, allowing it to be discarded after one procedure. This eliminates the need for complex sterilization processes and reduces the risk of cross-contamination, while the cost of the disposable unit is managed through efficient design and manufacturing.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Measurement precision

If plasma collection is monitored to pause or terminate at predetermined amounts, then treatment precision is improved, but system complexity increases

Engineering Contradiction:
Improveplasma collection precisionVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system incorporates automatic self-monitoring capabilities where sensors continuously measure the volume of plasma collected and feed this information to the programmable controller. The controller automatically compares the measured volume against predetermined targets and autonomously pauses or terminates the collection process when the target is reached, eliminating the need for constant manual monitoring and intervention.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

Manual monitoring and decision-making for plasma collection termination is replaced with an automated electronic control system. The programmable controller uses electronic sensors to monitor plasma volume in real-time and automatically executes the decision to pause or terminate collection based on pre-programmed parameters, substituting human judgment with precise electronic control.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables efficient and safe therapeutic plasma exchange by accurately collecting plasma and delivering replacement fluids or therapeutic agents, adapting to patient-specific needs and conditions, thereby enhancing treatment efficacy.

Implementation Method 1

The separation of the plasma from the cellular components is typically accomplished in an automated procedure by centrifugation or membrane filtration

Methodology Applied
Scientific EffectCentrifugation: Centrifugal Separation

Implementation Method 2

The separation of the plasma from the cellular components is typically accomplished in an automated procedure by centrifugation or membrane filtration

Methodology Applied
Scientific EffectMembrane filtration: Filter (physical)

Data Source

PatentUS12370295B2Therapeutic plasma exchange systems and methods
Publication Date: 2025.07.29 FENWAL INC
  • US12370295B2 patent drawing
  • US12370295B2 patent drawing
  • US12370295B2 patent drawing

AI summary

Systems and methods for performing therapeutic plasma exchange are provided. The systems and methods utilize a plasmapheresis device that includes a controller that is configured and/or programmed to monitor the amount plasma collected and initiate delivery of a therapeutic agent.